Results for tag: "Filgotinib"

Filgotinib is a drug used to treat immune disorders, such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. It is a Janus kinase (JAK) inhibitor, meaning it works by blocking the action of certain enzymes that are involved in the body's inflammatory response. It is taken orally and is available in both tablet and capsule form. Filgotinib is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2020. It is the first JAK inhibitor to be approved for the treatment of rheumatoid arthritis and is also the first oral medication to be approved for the treatment of Crohn's disease. Filgotinib is a promising treatment option for those suffering from immune disorders, as it has been shown to reduce symptoms and improve quality of life. It is also generally well-tolerated, with few side effects. Some companies in the Filgotinib market include Gilead Sciences, Galapagos, and AbbVie. Show Less Read more